Srs Capital Advisors, Inc. Gsk PLC Transaction History

Srs Capital Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$16.13 - $44.61 $13,613 - $37,650	-844 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$40.23 - $47.74 $1,367 - $1,623	-34 Reduced 3.87%	844 $37,000
Q4 2021 Feb 08, 2022	BUY	$38.88 - $45.31 $1,321 - $1,540	34 Added 4.03%	878 $39,000
Q3 2021 Nov 05, 2021	BUY	$38.79 - $43.16 $659 - $733	17 Added 2.06%	844 $32,000
Q2 2020 Aug 06, 2020	BUY	$37.87 - $43.58 $8,596 - $9,892	227 Added 37.83%	827 $34,000
Q2 2019 Aug 08, 2019	SELL	$39.4 - $42.7 $4,097 - $4,440	-104 Reduced 14.77%	600 $24,000
Q4 2018 Feb 06, 2019	SELL	$37.8 - $42.69 $10,508 - $11,867	-278 Reduced 28.31%	704 $27,000
Q3 2018 Nov 06, 2018	SELL	$39.75 - $42.69 $79,778 - $85,678	-2,007 Reduced 67.15%	982 $39,000
Q2 2018 Aug 21, 2018	BUY	$39.61 - $42.76 $4,753 - $5,131	120 Added 4.18%	2,989 $120,000
Q1 2018 May 14, 2018	BUY	$36.18 - $40.15 $40,051 - $44,446	1,107 Added 62.83%	2,869 $112,000
Q4 2017 Feb 15, 2018	BUY	$35.34 - $41.9 $3,145 - $3,729	89 Added 5.32%	1,762 $62,000
Q3 2017 Nov 15, 2017	BUY	$39.44 - $41.55 $65,983 - $69,513	1,673	1,673 $67,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Srs Capital Advisors, Inc. with notifications on news.